OBJECTIVE: Studies were made on the abnormality of glucose and lipid metabolism and its cause in four patients with Werner's syndrome to infer the reason for accelerated atherogenesis in this syndrome. RESULTS: Of these four patients, hypercholesterolemia was found in three, hypertriglyceridemia in four, hypoalphalipoproteinemia in two and hypertension in two. All the patients had insulin-resistant diabetes mellitus and three of them had apparent hyperinsulinemia. Abdominal computed tomography revealed that all of them had visceral fat obesity, namely augumented intra-abdominal adipose tissue. CONCLUSION: The clinical features of these patients resemble those recently designated as insulin resistant syndrome (syndrome X) or visceral fat syndrome. The metabolic abnormality may be one of important factors in the accelerated atherogenesis in this syndrome.
Introduction
Werner's syndrome is an autosomal recessive disease that causes premature ageing accompanied by an increased susceptibility to cancer. 1, 2 The causative gene (WRN) codes for a DNA helicase. 3 It has been reported that two major causes of death in Werner's syndrome are malignant neoplasms and atherosclerotic vascular diseases. 1 An elevated somatic mutation rate was observed in cells from Werner's syndrome patients, suggesting that higher occurrence of cancer is due to chromosomal instability. 2 Identi®cation of a mutated putative helicase as the gene product of WRN gives a reason for the chromosomal instability; however, the reason for accelerated atherogenesis in this syndrome still remains unclear.
Several clinical features of Werner's syndrome resemble those designated as insulin resistance syndrome (syndrome X) 4, 5 or visceral fat syndrome, 6 which include visceral fat accumulation, glucose intolerance (insulin resistance), hyperlipidemia and hypertension. Therefore, in the present study, we characterized the fat distribution as well as glucose and lipid metabolism in four patients with Werner's syndrome in an attempt to elucidate its relationship to the insulin resistance syndrome.
Subjects and methods

Patients
Four patients with Werner's syndrome were studied. Written informed consent was obtained from all the patients. The diagnosis was made based on their typical clinical manifestations of this syndrome. 1 The clinical characteristics of the patients are summarized in Table 1 . Germline mutations of WRN were examined in peripheral blood samples from the patients by methods described previously. 7, 8 All the patients were found to be homozygous for mutation 4, which was previously designated by Yu et al. 3 None of the patients had other diseases that would cause secondary hyperlipidemia and none were receiving any medication that would affect lipid metabolism. The patients examined in this study were not selected, but all the patients with this disease seen at this hospital during the last 2 y.
Analytical procedures of blood samples
Blood samples were obtained from the patients in the morning after overnight fasting. The blood glucose level was determined by the hexokinase method, immunoreactive insulin (IRI) by ELISA, HbA 1c by HPLC, and lipids by the enzyme method. The endogenous insulin secretion function was assessed by 75 g oral glucose tolerance test (OGTT). Measurements of plasma glucose level and serum IRI level were performed simultaneously on the same blood samples. Serum levels of total cholesterol, triglyceride and HDL cholesterol are presented as means of at least three determinations.
Measurement of fat distribution
Body fat distribution was assessed by computed tomography (CT) imaging, which was carried out according to the procedure of Tokunaga et al. 9 The intraperitoneal part, having the same density as the subcutaneous fat layer, was considered as the visceral fat area (VFA). The total cross-section area, subcutaneous fat area (SFA), muscle plus bone, intraperitoneal area, and VFA were measured at the umbilicus level in all the patients. The ratio of the intra-abdominal VFA to SFA (VaS ratio), which was adopted as an index of the relative increase of visceral fat, was calculated. The patients with a VaS ratio of more than 0.4, or a VFA of more than 100 cm 2 , are designated as having visceral fat obesity, according to Yamashita et al. 6 
Results
The laboratory ®ndings of the patients are shown in Table 1 . Three patients had hypercholesterolemia and four had hypertriglyceridemia. Two patients had hypoalphalipoproteinemia and the other two had relatively low levels of serum HDL cholesterol. According to the WHO classi®cation of hyperlipidemia, these hyperlipidemias should be classi®ed as type IIb (cases 1, 2 and 4) and type IV (case 3).
As shown in Table 1 , fasting plasma glucose was high in two patients and HbA 1c was high in three patients. Fasting serum IRI was absolutely high in three patients (cases 1 ± 3) and relatively high in one patient (case 4). Figure 1 shows the glucose and IRI responses to 75 g OGTT in three patients examined (cases 1 ± 3). All of them showed diabetic glucose response; the plasma glucose level for 120 min after glucose ingestion was more than 11.2 mmol l À1 . The IRI response was delayed but extremely ampli®ed in all three patients; the serum IRI level for 120 min after glucose ingestion was more than 200 mU ml À1 . As judged by these data, all the patients had insulin-resistant diabetes mellitus.
Abdominal CT ®ndings of the patients are shown in Figure 2 . Marked accumulation of visceral fat was clearly detected in all the patients. Table 2 shows values for VFA, SFA and VaS ratio of the patients. Although the VFA was less than 100 cm 2 in two patients, the VaS ratio was extremely high in all the patients, indicating that all of them had preserved 
Discussion
The present study demonstrates that all the patients with Werner's syndrome examined have hyperlipidemia (Table 1) . Our results also show that they have insulin-resistant diabetes mellitus (Table 1, Figure 1 ) as well as relative visceral fat obesity (Table 2, Figure 2 ). Furthermore, two of them have hypertension (Table 1) , although the precise cause of it has not been determined. Thus, the clinical features of these patients resemble insulin resistance syndrome (syndrome X) 4,5 or visceral fat syndrome. 6 It was previously reported that, in a case of Werner's syndrome, intravenous glucose tolerance test showed a reduced glucose tolerance coupled with very high insulin levels. 10 The observation is further con®rmed by our present study. Hyperinsulinemia by itself cannot explain pathogenesis of a striking feature of this disease, namely, the contrast between lipoatrophy in the subcutaneous tissue of the extremities and augumented intra-abdominal adipose tissue. Metabolic studies with isolated subcutaneous adipocytes from a patient with Werner's syndrome showed evidence of increased lipolytic response to catecholamines, diminished binding of insulin and decreased antilipolytic effect of this hormone. 11 Therefore, it is possible that the sensitivity of adipocytes to insulin is quite Visceral fat obesity in Werner's syndrome S Mori et al different between the subcutaneous and intra-abdominal adipose tissues in this condition; the former is resistant while the latter seems to be rather sensitive.
Vannini et al 12 reported that hyperinsulinemia of a patient with Werner's syndrome was possibly caused not only by marked insulin resistance but also by reduced metabolic clearance rate of insulin. However, the reason for insulin resistance in this syndrome has not been fully understood. Serum levels of free fatty acids and tumor necrosis factor-a were not found to be increased in our four patients (data not shown), indicating that their insulin resistance cannot be explained simply by these factors. It has recently been experimentally proven that, in lipoatrophic diabetes, a lack of fat is directly associated with insulin resistance and hyperglycemia. 13 It is suggested that lack of subcutaneous fat leads to increased triglyceride accumulation in muscles which, in turn, can lead to insulin resistance.
14 It is thus conceivable that the lipoatrophy of the extremities contributes at least partly to insulin resistance in this syndrome. Further study is necessary to prove this possibility.
